ProBioGen GIBCO

ProBioGen co-develops new Freedom ExpiCHO-S cell line development kit

Following the success of the Gibco Freedom CHO-S Cell Line Development Kit, ProBioGen and Thermo Fisher Scientific have teamed up again to develop an even better platform: the Gibco Freedom ExpiCHO-S Cell Line Development Kit. It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience […]

Novitain Screwtop Tube

Novitain launches labware solution that guarantees sample traceability with 2D coded screwtop tubes

Novitain has launched a complete labware solution in SBS-format, including the Novitain 0.75ml Screwtop Tubes with 2D Data-Matrix code on the bottom, to process samples safely and traceably. The Novitain Screwtop Tubes have an internal or external thread and they can be capped with either the: Seal Mats Flex, Seal Mats & Strips Solid or […]

amsbio VSV

AMSBIO adds new range of virus-based tools for cell engineering

AMSBIO has added a new range of Vesicular Stomatitis Virus (VSV) to its suite of virus-based tools for cell engineering and the study of viral infection.

Thermo Scientific EXTREVA

Thermo Scientific’s first all-in-one, fully automated sample preparation system set to revolutionize chromatography workflows

Laboratories performing environmental, food, and biopharmaceutical testing can now increase productivity, reduce errors, and minimize personnel time and solvent use with a new, all-in-one, automated chromatography sample preparation system.

EKF DiaSpect

EKF introduces hand-held hemoglobin analyzer with secure POC connectivity

EKF Diagnostics, a global in vitro diagnostics company, has unveiled an improved handheld hemoglobin analyzer – DiaSpect Tm. The analyzer now connects securely to EKF Link, the company’s point-of-care (POC) middleware, enabling additional features including a calculated hematocrit value and data management.

Ellutia nitrosamine

Ellutia releases fully automated total nitrosamine testing system

Ellutia is releasing its newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and sensitivity, so it can quickly identify whether or not nitrosamines are present down to 1ppb levels.

waters SPE

Waters automates solid phase extraction of biological, food and environmental samples with Andrew+ Pipetting Robot

Waters Corporation has introduced their Extraction+ Connected Device, a new software-controlled product for the Waters Andrew+ Pipetting Robot that automates the preparation of biological, food, forensics and environmental samples by solid phase extraction (SPE). The Extraction+ Connected Device eliminates the need to manually pipette and extract samples with a hands-free, automated approach to SPE. It […]

Ardigen Logo

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]

GenNext Fox

GenNext wins $250,000 Grand Prize Award at 2022 BioTools Innovator competition

GenNext Technologies, a growth-stage company that provides instrumentation, software, and services to pharmaceutical researchers, was awarded the 2022 Grand Prize Award in the BioTools Innovator competition.

Oncodesign

Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.